Kiora Pharmaceuticals Inc (KPRX)

03:56 AM

What is the risk reward ratio of investing in Kiora Pharmaceuticals Inc. stockMaximize portfolio value with smart investment plans - jammulinksnews.com

03:56 AM

03:47 AM

What are the latest earnings results for Kiora Pharmaceuticals Inc.Phenomenal trading returns - jammulinksnews.com

03:47 AM

10:07 AM

Kiora Pharmaceuticals Inc. Stock Support and Resistance Levels You Should KnowFree Trading Group - Newser

10:07 AM

09:46 AM

Why Kiora Pharmaceuticals Inc. stock attracts strong analyst attentionProfitable Yet Secure Picks - Newser

09:46 AM

06:41 AM

Can Kiora Pharmaceuticals Inc. stock recover from recent declineCapital Protected Stock Selections - Newser

06:41 AM

06:39 AM

Kiora Pharmaceuticals Inc. Company Revenue and Profit Trends: A Deep DiveProfitable Yet Secure Picks - Newser

06:39 AM

02:33 AM

What makes Kiora Pharmaceuticals Inc. stock price move sharplyBreakout Momentum Alerts - Newser

02:33 AM

Jul 25, 2025

What drives Kiora Pharmaceuticals Inc. stock priceDynamic investment opportunities - Autocar Professional

Jul 25, 2025

Jul 25, 2025

What analysts say about Kiora Pharmaceuticals Inc. stockPhenomenal trading returns - PrintWeekIndia

Jul 25, 2025

Jul 24, 2025

Kiora Pharmaceuticals Secures US Patent for KIO-104 - Ophthalmology Times

Jul 24, 2025

Jul 23, 2025

Kiora Pharmaceuticals Inc. Stock Analysis and ForecastExtraordinary market timing - Autocar Professional

Jul 23, 2025

Jul 23, 2025

Is Kiora Pharmaceuticals Inc. a good long term investmentPowerful profit generation - jammulinksnews.com

Jul 23, 2025

Jul 22, 2025

KPRX Receives Positive Outlook Following New U.S. Patent | KPRX Stock News - GuruFocus

Jul 22, 2025

Jul 22, 2025

Kiora Pharmaceuticals stock rises after receiving patent for KIO-104 - Investing.com India

Jul 22, 2025

Jul 22, 2025

Kiora Pharmaceuticals stock rises after receiving patent for KIO-104 By Investing.com - Investing.com Nigeria

Jul 22, 2025

Jul 22, 2025

Kiora Pharmaceuticals receives patent for ocular disease treatment By Investing.com - Investing.com South Africa

Jul 22, 2025

Jul 22, 2025

Kiora Pharmaceuticals receives patent for ocular disease treatment - Investing.com Australia

Jul 22, 2025

Jul 22, 2025

Kiora Secures Crucial Patent for Eye Disease Drug KIO-104 as Phase 2 Trial Advances - Stock Titan

Jul 22, 2025

Jul 17, 2025

Kiora Pharmaceuticals (KPRX) Upgraded to Strong Buy: Here's What You Should Know - MSN

Jul 17, 2025

Jul 16, 2025

Retinitis Pigmentosa Treatment Market Driven by Gene Therapy - openPR.com

Jul 16, 2025

Jul 15, 2025

How Kiora Pharmaceuticals Inc. stock performs during market volatilityFree Smart Money Stock Analysis - Newser

Jul 15, 2025

Jul 09, 2025

Kiora Pharmaceuticals (NASDAQ:KPRX) Trading 1.8% Higher – Here’s Why - Defense World

Jul 09, 2025

Jun 17, 2025

Kiora Pharmaceuticals (NASDAQ:KPRX) Trading Down 0.3% – Here’s Why - Defense World

Jun 17, 2025

Jun 05, 2025

Kiora Pharmaceuticals and Senju Pharmaceutical partner on KIO-301 for retinal disease treatment in Asia - Ophthalmology Times

Jun 05, 2025

Jun 04, 2025

kiora pharmaceuticals reports results of annual shareholder meeting By Investing.com - Investing.com South Africa

Jun 04, 2025